Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose IVIG plus antiretroviral therapy in HIV infection
2005-003422-26Phase 2Active
- Sponsor
- University of Gothenburg
- Start
- Mar 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of immune globulin in human immunodeficiency virus infection (HIV), sponsored by University of Gothenburg. Primary endpoint: Decrease in HIV-1 DNA in PBMC. Started Mar 2006; status: active.
02
Drugs
immune globulin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2005-003422-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003422-26.